tiprankstipranks
France Bed Holdings Co., Ltd. (JP:7840)
:7840
Japanese Market

France Bed Holdings Co., Ltd. (7840) AI Stock Analysis

0 Followers

Top Page

JP:7840

France Bed Holdings Co., Ltd.

(7840)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 5.2)
Rating:75Outperform
Price Target:
¥1,451.00
▲(8.61% Upside)
Action:ReiteratedDate:09/05/25
France Bed Holdings Co., Ltd. scores well due to its strong financial performance and reasonable valuation. The technical analysis shows a positive trend, though some caution is warranted due to bearish momentum signals. The absence of earnings call data and corporate events does not impact the score.
Positive Factors
Revenue Growth
Consistent revenue growth indicates expanding market presence and effective sales strategies, supporting long-term business sustainability.
Negative Factors
Decline in Free Cash Flow Growth
A decline in free cash flow growth may limit the company's ability to invest in new opportunities or return capital to shareholders.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Consistent revenue growth indicates expanding market presence and effective sales strategies, supporting long-term business sustainability.
Read all positive factors

France Bed Holdings Co., Ltd. (7840) vs. iShares MSCI Japan ETF (EWJ)

France Bed Holdings Co., Ltd. Business Overview & Revenue Model

Company Description
France Bed Holdings Co.,Ltd., through its subsidiaries, engages in the medical services, and home furnishing and health businesses in Japan. It manufactures, purchases, rents, retails, and wholesales medical beds, special needs equipment, beds, be...
How the Company Makes Money
France Bed Holdings generates revenue through the sale of its various bedding products, which include high-quality mattresses, bed frames, and sleep-related accessories. The company operates through multiple sales channels, including direct-to-con...

France Bed Holdings Co., Ltd. Financial Statement Overview

Summary
France Bed Holdings Co., Ltd. demonstrates a solid financial position with strong revenue growth and stable margins. The balance sheet is robust with effective debt management and solid equity levels. While cash flow remains strong, careful attention is needed to manage free cash flow growth and capital expenditures.
Income Statement
85
Very Positive
Balance Sheet
80
Positive
Cash Flow
78
Positive
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2021
Income Statement
Total Revenue60.11B60.56B59.15B58.58B54.40B52.43B
Gross Profit33.07B33.06B31.89B31.19B29.00B27.04B
EBITDA9.77B10.00B10.39B10.28B9.49B8.53B
Net Income2.77B2.95B3.13B2.70B2.56B2.29B
Balance Sheet
Total Assets67.98B70.89B68.58B64.68B64.30B62.22B
Cash, Cash Equivalents and Short-Term Investments15.20B17.22B16.70B12.86B11.28B12.80B
Total Debt12.84B17.21B18.32B14.34B15.39B12.47B
Total Liabilities29.32B30.28B30.36B26.55B26.75B24.80B
Stockholders Equity38.67B40.61B38.21B38.12B37.54B37.41B
Cash Flow
Free Cash Flow0.002.71B3.06B4.13B-568.00M3.67B
Operating Cash Flow0.007.45B7.83B8.93B6.01B10.41B
Investing Cash Flow0.00-4.93B-5.62B-6.69B-7.78B-7.00B
Financing Cash Flow0.00-2.50B633.00M-2.66B316.00M-1.92B

France Bed Holdings Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1336.00
Price Trends
50DMA
1311.90
Positive
100DMA
1309.31
Positive
200DMA
1283.67
Positive
Market Momentum
MACD
9.78
Negative
RSI
53.97
Neutral
STOCH
64.93
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7840, the sentiment is Positive. The current price of 1336 is above the 20-day moving average (MA) of 1313.88, above the 50-day MA of 1311.90, and above the 200-day MA of 1283.67, indicating a bullish trend. The MACD of 9.78 indicates Negative momentum. The RSI at 53.97 is Neutral, neither overbought nor oversold. The STOCH value of 64.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7840.

France Bed Holdings Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥177.24B11.814.91%6.35%14.05%
75
Outperform
¥46.20B13.602.97%0.89%-14.25%
72
Outperform
¥185.37B8.203.41%6.17%61.39%
67
Neutral
¥183.12B17.502.20%7.63%29.07%
66
Neutral
¥9.41B3.192.65%1.11%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
58
Neutral
¥3.34B10.544.00%11.73%37.16%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7840
France Bed Holdings Co., Ltd.
1,327.00
124.07
10.31%
JP:7791
DREAMBED CO.,LTD.
811.00
86.73
11.97%
JP:7898
Wood One Co., Ltd.
1,003.00
144.14
16.78%
JP:7972
Itoki Corporation
3,480.00
1,957.87
128.63%
JP:7981
Takara Standard Co., Ltd
2,932.00
1,261.01
75.46%
JP:8130
Sangetsu Corporation
3,045.00
362.26
13.50%

France Bed Holdings Co., Ltd. Corporate Events

France Bed Holdings Reports Stable Sales Amid Profit Decline
Dec 10, 2025
France Bed Holdings Co., Ltd. reported its consolidated financial results for the six months ended September 30, 2025, showing stable net sales but a decline in profits compared to the previous year. The company maintained its dividend forecast, i...
France Bed Holdings Adjusts Convertible Bond Conversion Price
Nov 7, 2025
France Bed Holdings Co., Ltd. announced an adjustment to the conversion price of its Zero Coupon Convertible Bonds due 2029, reducing it from 1,334.8 yen to 1,317.1 yen. This adjustment follows the approval of an interim dividend of 17 yen per sha...
France Bed Holdings Reports Stable Sales Amid Profit Decline
Nov 7, 2025
France Bed Holdings Co., Ltd. reported its consolidated financial results for the six months ended September 30, 2025, showing stable net sales but a decline in profits compared to the previous year. The company maintained its dividend forecast, r...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 05, 2025